Clinical Trial Update: A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing two subcutaneous concentrations of dapiglutide to evaluate pharmacokinetics, safety, and tolerability has completed. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Dapiglutide (dapiglutide)

Snippet

Sponsor: Zealand Pharma | Conditions: Overweight and Obesity | Phase 1 | Status: COMPLETED